<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Imaging should be included in the workup of <z:hpo ids='HP_0000726'>dementia</z:hpo> patients and is mandatory for the diagnosis of vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VaD) </plain></SENT>
<SENT sid="1" pm="."><plain>MRI is the preferred imaging modality and should include axial T2 and FLAIR, preferably accompanied by a 3D T1-weighted sequence in clinical trials to determine white-matter lesions, <z:mpath ids='MPATH_124'>infarcts</z:mpath>, lacunes, and <z:mpath ids='MPATH_127'>atrophy</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>Gradient echo images are needed for microbleeds </plain></SENT>
<SENT sid="3" pm="."><plain>Diagnostic criteria should be operationalized and validated visual rating scales are available </plain></SENT>
<SENT sid="4" pm="."><plain>In clinical trials, standardized acquisition protocols and central data analysis are mandatory </plain></SENT>
<SENT sid="5" pm="."><plain>More work is needed to determine the natural progression in VaD and the possible use of MRI-based outcome measures </plain></SENT>
</text></document>